09
Sep
Venture capital stalwart OrbiMed Advisors has closed a $325 million new fund, cash earmarked for biotech investments in Asia.
Source: OrbiMed Advisors banks $325M for a new round of Asian biotech bets
Venture capital stalwart OrbiMed Advisors has closed a $325 million new fund, cash earmarked for biotech investments in Asia.
Source: OrbiMed Advisors banks $325M for a new round of Asian biotech bets
